Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Extendicare price target lowered to C$7.50 from C$7.75 at RBC Capital » 10:58
05/22/20
05/22
10:58
05/22/20
10:58
EXETF

Extendicare

$0.00 /

+ (+0.00%)

RBC Capital analyst Pammi…

RBC Capital analyst Pammi Bir lowered the firm's price target on Extendicare to C$7.50 from C$7.75 and keeps a Sector Perform rating on the shares.

ShowHide Related Items >><<
EXETF Extendicare
$0.00 /

+ (+0.00%)

05/19/20 TD Securities
Extendicare price target lowered to C$6.50 from C$7 at TD Securities
05/19/20 National Bank
Extendicare price target lowered to C$6 from C$7 at National Bank
04/29/20 CIBC
Extendicare downgraded to Neutral from Outperformer at CIBC
04/02/20 RBC Capital
Extendicare price target lowered to C$7.75 from C$8.75 at RBC Capital
Over a week ago
Recommendations
Extendicare price target lowered to C$6.50 from C$7 at TD Securities » 15:44
05/19/20
05/19
15:44
05/19/20
15:44
EXETF

Extendicare

$0.00 /

+ (+0.00%)

TD Securities analyst…

TD Securities analyst Jonathan Kelcher lowered the firm's price target on Extendicare to C$6.50 from C$7 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
EXETF Extendicare
$0.00 /

+ (+0.00%)

05/19/20 National Bank
Extendicare price target lowered to C$6 from C$7 at National Bank
04/29/20 CIBC
Extendicare downgraded to Neutral from Outperformer at CIBC
04/02/20 RBC Capital
Extendicare price target lowered to C$7.75 from C$8.75 at RBC Capital
Recommendations
Extendicare price target lowered to C$6 from C$7 at National Bank » 11:16
05/19/20
05/19
11:16
05/19/20
11:16
EXETF

Extendicare

$0.00 /

+ (+0.00%)

National Bank analyst Tal…

National Bank analyst Tal Woolley lowered the firm's price target on Extendicare to C$6 from C$7 and keeps a Sector Perform rating on the shares.

ShowHide Related Items >><<
EXETF Extendicare
$0.00 /

+ (+0.00%)

04/29/20 CIBC
Extendicare downgraded to Neutral from Outperformer at CIBC
04/02/20 RBC Capital
Extendicare price target lowered to C$7.75 from C$8.75 at RBC Capital
Downgrade
Extendicare downgraded to Neutral from Outperformer at CIBC » 06:19
04/29/20
04/29
06:19
04/29/20
06:19
EXETF

Extendicare

$0.00 /

+ (+0.00%)

CIBC analyst Chris…

CIBC analyst Chris Couprie downgraded Extendicare to Neutral from Outperformer with a price target of C$8, down from C$8.50. The analyst says the thesis for a recovery at ParaMed is now challenged, and that it will likely take into 2021 to see if volumes and margins are going to expand.

ShowHide Related Items >><<
EXETF Extendicare
$0.00 /

+ (+0.00%)

04/02/20 RBC Capital
Extendicare price target lowered to C$7.75 from C$8.75 at RBC Capital
Over a month ago
Recommendations
Extendicare price target lowered to C$7.75 from C$8.75 at RBC Capital » 12:04
04/02/20
04/02
12:04
04/02/20
12:04
EXETF

Extendicare

$0.00 /

+ (+0.00%)

RBC Capital analyst Pammi…

RBC Capital analyst Pammi Bir lowered the firm's price target on Extendicare to C$7.75 from C$8.75 and keeps a Sector Perform rating on the shares. The firm reduced its price target to reflect the expected impact of the COVID-19 pandemic, and the analyst noted that there is potential for further revisions.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.